Metropolitan Life Insurance Company (MetLife)’s Revolve Group RVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,328
Closed -$49.3K 1711
2024
Q1
$49.3K Hold
2,328
﹤0.01% 1411
2023
Q4
$38.6K Hold
2,328
﹤0.01% 1586
2023
Q3
$31.7K Hold
2,328
﹤0.01% 1653
2023
Q2
$38.2K Buy
+2,328
New +$43.4K ﹤0.01% 1588
2023
Q1
Sell
-2,631
Closed -$58.6K 2440
2022
Q4
$58.6K Buy
2,631
+249
+10% +$5.98K ﹤0.01% 1369
2022
Q3
$51.7K Hold
2,382
﹤0.01% 1443
2022
Q2
$61.7K Hold
2,382
﹤0.01% 1360
2022
Q1
$128K Sell
2,382
-7,031
-75% -$357K ﹤0.01% 1049
2021
Q4
$528K Sell
9,413
-747
-7% -$52.5K 0.01% 1385
2021
Q3
$628K Buy
+10,160
New +$661K 0.01% 1297

Other funds holding RVLV

Metropolitan Life Insurance Company (MetLife)'s RVLV Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Revolve Group (RVLV) in Q2 2024, closing a stake of 2,328 shares — an estimated $49.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RVLV in Q3 2021 and held it in 10 quarters. The position peaked at $628K in Q3 2021. 195 funds tracked by Wall St. Rank hold RVLV as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Revolve Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,328 Revolve Group shares in Q2 2024, an estimated $49.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Revolve Group in Q3 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Revolve Group position peaked at $628K in Q3 2021.
  • 195 funds tracked by Wall St. Rank held Revolve Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.